Analysis of Immunotherapy in Triple negative breast cancer
-
Fecha
2022 -
Editorial/Editor
Aseica -
Palabras clave
Inmunoterapia - Congresos; Cancer - Congresos -
Resumen
TNBC cancer is complicated, most is about PD-L1 mechanism. Too many kinds of immunotherapy have been developed to treat TNCB. Nowadays, is complicated a fast and 100% accurate treatment for TNBC, because of cancer complications like metastasis. Nevertheless, metastasis is still being researched to prevent it and assure a better immunotherapy. Also, the immunotherapies must be improved too.